ArticleNeoplasia (New York, N.Y.)2014

Erratum to "Doubling Down on the PI3K-AKTmTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness" [Neoplasia 16 (2014) 43-72].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.